Old Web
English
Sign In
Acemap
>
authorDetail
>
Qiuxia Dong
Qiuxia Dong
Chemistry
Cancer research
Cancer
Fibroblast growth factor receptor
Tyrosine kinase
4
Papers
108
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II Study.
2021
OncoTargets and Therapy
Dengfeng Ren
Guoxiu Wang
Yu Zhang
Jie Kan
Qiuxia Dong
Junhui Zhao
Faxiang Ji
Hao Li
Yushuang Luo
Mingzhe Lin
Guoyuan Li
Zhibo Liu
Xinfu Ma
Qijing Guo
Fuxing Zhao
Guoshuang Shen
Jiuda Zhao
Show All
Source
Cite
Save
Citations (0)
Discovery of SCY45, a natural small‐molecule MDM2‐P53 interaction inhibitor
2019
Chemistry & Biodiversity
Haifeng Gong
Juan An
Qiuxia Dong
Jinxian Li
Wei Yang
Wei Sun
Zhanhai Su
Shou-De Zhang
Show All
Source
Cite
Save
Citations (1)
Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
2018
Journal of Hematology & Oncology
Guoshuang Shen
Fangchao Zheng
Dengfeng Ren
Feng Du
Qiuxia Dong
Ziyi Wang
Fuxing Zhao
Raees Ahmad
Jiuda Zhao
Show All
Source
Cite
Save
Citations (105)
1